These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22471477)

  • 21. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
    Ge Z; Liu Z; Hu X
    World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis.
    Kong F; Qi Y; Liu H; Gao F; Yang P; Li Y; Jia Y
    Clin Transl Oncol; 2015 Nov; 17(11):917-24. PubMed ID: 26088414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
    Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
    World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
    Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
    Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
    Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
    Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH
    World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?
    Solomon NL; Cheung MC; Byrne MM; Zhuge Y; Franceschi D; Livingstone AS; Koniaris LG
    Ann Surg Oncol; 2010 Jan; 17(1):98-108. PubMed ID: 19777191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
    Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
    Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of third-generation epirubicin/cisplatin/xeloda adjuvant chemotherapy in patients with radically resected gastric cancer.
    Cainap C; Nagy V; Seicean A; Gherman A; Laszlo I; Lisencu C; Nadim AH; Constantin AM; Cainap S
    J BUON; 2016; 21(2):349-59. PubMed ID: 27273944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse effect of mucinous component on survival in stage III colorectal cancer.
    Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K
    J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding.
    Wang L; Wang XA; Hao JQ; Zhang LN; Li ML; Wu XS; Weng H; Lv WJ; Zhang WJ; Chen L; Xiang HG; Lu JH; Liu YB; Dong P
    World J Gastroenterol; 2015 Dec; 21(47):13316-24. PubMed ID: 26715815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry.
    Schlesinger-Raab A; Mihaljevic AL; Egert S; Emeny R; Jauch KW; Kleeff J; Novotny A; Nüssler NC; Rottmann M; Schepp W; Schmitt W; Schubert-Fritschle G; Weber B; Schuhmacher C; Engel J
    Gastric Cancer; 2016 Jul; 19(3):713-22. PubMed ID: 26260874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
    Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma.
    Chen H; Shen C; Yin R; Yin Y; Chen J; Han L; Zhang B; Chen Z; Chen J
    World J Surg Oncol; 2015 Apr; 13():136. PubMed ID: 25889482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.